Cellcolabs raised €8.0M in a funding round in Mar 2024. The company is based in Solna, Sweden. Investors in the round: Filip Engelbert, Fredrik Österberg, Jens von Bahr and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
